塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2011/06/01 | 1,351 | 1,365 | 1,342 | 1,360 | -13 | -0.9% | 1,521,400 |
2011/05/31 | 1,345 | 1,373 | 1,340 | 1,373 | +26 | +1.9% | 1,318,000 |
2011/05/30 | 1,341 | 1,349 | 1,334 | 1,347 | +4 | +0.3% | 778,600 |
2011/05/27 | 1,344 | 1,352 | 1,333 | 1,343 | -7 | -0.5% | 1,207,200 |
2011/05/26 | 1,343 | 1,352 | 1,336 | 1,350 | +13 | +1% | 1,097,100 |
2011/05/25 | 1,334 | 1,340 | 1,325 | 1,337 | +10 | +0.8% | 1,028,800 |
2011/05/24 | 1,313 | 1,330 | 1,309 | 1,327 | +18 | +1.4% | 1,107,400 |
2011/05/23 | 1,305 | 1,313 | 1,301 | 1,309 | +2 | +0.2% | 1,048,800 |
2011/05/20 | 1,306 | 1,318 | 1,304 | 1,307 | -4 | -0.3% | 909,600 |
2011/05/19 | 1,313 | 1,324 | 1,305 | 1,311 | +4 | +0.3% | 777,400 |
2011/05/18 | 1,310 | 1,317 | 1,305 | 1,307 | +3 | +0.2% | 874,100 |
2011/05/17 | 1,290 | 1,308 | 1,286 | 1,304 | +13 | +1% | 1,048,800 |
2011/05/16 | 1,277 | 1,298 | 1,269 | 1,291 | +17 | +1.3% | 1,701,600 |
2011/05/13 | 1,307 | 1,312 | 1,260 | 1,274 | -40 | -3% | 3,447,100 |
2011/05/12 | 1,324 | 1,336 | 1,314 | 1,314 | -15 | -1.1% | 913,800 |
2011/05/11 | 1,349 | 1,349 | 1,326 | 1,329 | -7 | -0.5% | 1,165,700 |
2011/05/10 | 1,348 | 1,354 | 1,336 | 1,336 | -10 | -0.7% | 1,082,800 |
2011/05/09 | 1,318 | 1,364 | 1,318 | 1,346 | +18 | +1.4% | 1,762,900 |
2011/05/06 | 1,312 | 1,330 | 1,309 | 1,328 | +8 | +0.6% | 1,101,200 |
2011/05/02 | 1,324 | 1,327 | 1,312 | 1,320 | +8 | +0.6% | 1,108,200 |
2011/04/28 | 1,310 | 1,321 | 1,299 | 1,312 | +1 | +0.1% | 2,219,500 |
2011/04/27 | 1,303 | 1,314 | 1,301 | 1,311 | -7 | -0.5% | 1,728,200 |
2011/04/26 | 1,296 | 1,325 | 1,290 | 1,318 | -61 | -4.4% | 2,966,500 |
2011/04/25 | 1,395 | 1,408 | 1,376 | 1,379 | -16 | -1.1% | 635,400 |
2011/04/22 | 1,402 | 1,412 | 1,394 | 1,395 | -20 | -1.4% | 706,700 |
2011/04/21 | 1,412 | 1,420 | 1,400 | 1,415 | +22 | +1.6% | 860,200 |
2011/04/20 | 1,382 | 1,403 | 1,382 | 1,393 | +32 | +2.4% | 1,133,900 |
2011/04/19 | 1,368 | 1,380 | 1,360 | 1,361 | -18 | -1.3% | 667,400 |
2011/04/18 | 1,378 | 1,391 | 1,369 | 1,379 | -3 | -0.2% | 725,200 |
2011/04/15 | 1,382 | 1,386 | 1,374 | 1,382 | -7 | -0.5% | 1,053,700 |
2011/04/14 | 1,399 | 1,403 | 1,380 | 1,389 | -27 | -1.9% | 1,389,200 |
2011/04/13 | 1,414 | 1,429 | 1,410 | 1,416 | +1 | +0.1% | 1,270,400 |
2011/04/12 | 1,428 | 1,432 | 1,409 | 1,415 | -36 | -2.5% | 951,500 |
2011/04/11 | 1,430 | 1,455 | 1,422 | 1,451 | +16 | +1.1% | 1,134,400 |
2011/04/08 | 1,414 | 1,445 | 1,399 | 1,435 | +25 | +1.8% | 1,700,800 |
2011/04/07 | 1,418 | 1,419 | 1,403 | 1,410 | ±0 | ±0% | 877,800 |
2011/04/06 | 1,435 | 1,443 | 1,410 | 1,410 | +10 | +0.7% | 1,710,000 |
2011/04/05 | 1,417 | 1,437 | 1,391 | 1,400 | +4 | +0.3% | 1,901,400 |
2011/04/04 | 1,408 | 1,417 | 1,396 | 1,396 | -6 | -0.4% | 659,700 |
2011/04/01 | 1,412 | 1,429 | 1,401 | 1,402 | -17 | -1.2% | 1,069,200 |
2011/03/31 | 1,401 | 1,422 | 1,393 | 1,419 | +22 | +1.6% | 1,264,500 |
2011/03/30 | 1,373 | 1,397 | 1,365 | 1,397 | +24 | +1.7% | 1,038,300 |
2011/03/29 | 1,358 | 1,379 | 1,352 | 1,373 | -4 | -0.3% | 1,478,600 |
2011/03/28 | 1,392 | 1,395 | 1,366 | 1,377 | -7 | -0.5% | 865,800 |
2011/03/25 | 1,372 | 1,386 | 1,369 | 1,384 | +22 | +1.6% | 907,700 |
2011/03/24 | 1,379 | 1,380 | 1,356 | 1,362 | -10 | -0.7% | 1,194,800 |
2011/03/23 | 1,394 | 1,420 | 1,365 | 1,372 | -20 | -1.4% | 1,903,900 |
2011/03/22 | 1,380 | 1,400 | 1,365 | 1,392 | +62 | +4.7% | 2,412,800 |
2011/03/18 | 1,355 | 1,379 | 1,316 | 1,330 | -25 | -1.8% | 2,495,400 |
2011/03/17 | 1,270 | 1,369 | 1,244 | 1,355 | +82 | +6.4% | 3,960,800 |
3301~
3350
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 207,700円 | +5.7% | +3.9% | 2.76% | 10.33倍 | 1.36倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 888,900円 | +14.4% | +120.8% | 1.35% | 19.95倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.92倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 463,100円 | +1.7% | -2.9% | 3.45% | 30.38倍 | 1.59倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 252,500円 | +11.3% | -5.4% | 2.30% | 19.44倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム